This effect was not observed with istradefylline 20 mg/day.

Does Dual Combination Therapy Work?

diltiazemdiltiazem will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. diltiazem will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. dronedaronedronedarone will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. dronedarone will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. duvelisibduvelisib will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Usual Adult Dose for:

Coadministration with duvelisib increases AUC of a sensitive CYP3A4 substrate which may increase the risk of toxicities of these drugs. Consider reducing the dose of the sensitive CYP3A4 substrate and monitor for signs of toxicities of the coadministered sensitive CYP3A substrate. duvelisib will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenzefavirenz will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Potent CYP3A4 inducers are expected to cause substantial decreases in sildenafil plasma levels efavirenz will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

1. Regulatory Documentation Provided

Potent CYP3A4 inducers are expected to cause substantial decreases in sildenafil plasma levels elagolixelagolix decreases levels of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Consider increasing CYP3A substrate dose if needed. elagolix decreases levels of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Encorafenib both inhibits and induces CYP3A4 at clinically relevant plasma concentrations. Coadministration of encorafenib with sensitive CYP3A4 substrates may result in increased toxicity or decreased efficacy of these agents. Consider dose reduction of sensitive CYP3A4 substrates. istradefylline will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Product	Dosage	Quantity + Bonus	Price
Kamagra Polo	100mg	32 Pills	125.88€ 119.89€
Viagra Generic	25mg	180 + 6 Pills	154.93€ 147.55€
Viagra Generic	100mg	90 + 6 Pills	129.02€ 122.88€
Viagra Generic	50mg	90 + 6 Pills	107.37€ 102.26€
Viagra Generic	50mg	360 + 10 Pills	225.33€ 214.60€
Viagra Generic	50mg	270 + 8 Pills	198.48€ 189.03€
Kamagra	100mg	360 + 6 Pills	839.95€ 799.95€
Viagra Generic	150mg	30 + 2 Pills	72.32€ 68.88€
Kamagra Oral Jelly	100mg	21 Sachets	95.92€ 91.35€
Kamagra Polo	100mg	20 Pills	83.56€ 79.58€
Viagra Generic	25mg	270 + 8 Pills	184.26€ 175.49€
Kamagra	100mg	120 + 6 Pills	330.74€ 314.99€
Viagra Generic	200mg	180 + 10 Pills	277.56€ 264.34€
Kamagra	100mg	12 Pills	55.64€ 52.99€
Viagra Generic	200mg	120 + 8 Pills	204.80€ 195.05€
Viagra Generic	150mg	270 + 10 Pills	326.61€ 311.06€
Kamagra Soft Tabs	100mg	20 Pills	79.79€ 75.99€

itraconazoleitraconazole will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Not recommended during and 2 weeks after itraconazole treatment when sildenafil is used for pulmonary arterial hypertension.

Sildenafil citrate sublingual tablets facilitate quicker onset compared to oral forms.
They are prescribed for erectile dysfunction and pulmonary hypertension treatment.
Proper placement under the tongue ensures rapid absorption.
Do not use if pregnant or breastfeeding.
Patients with cardiac issues should get clearance from a doctor before use.
Side effects can include muscle aches, flushing, or nasal congestion.
Avoid use with other erectile dysfunction treatments.
Inform your healthcare provider about all medical conditions.
The medication may interact with certain antifungals and antibiotics.
Never take medication that is expired or stored improperly.
Always follow the instructions provided with the medication.

itraconazole will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Key takeawaysAI

Potent CYP3A4 inducers are expected to cause substantial decreases in sildenafil plasma levels etravirine will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Potent CYP3A4 inducers are expected to cause substantial decreases in sildenafil plasma levels fedratinibfedratinib will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Adjust dose of drugs that are CYP3A4 substrates as necessary. fedratinib will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fluconazolefluconazole will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Mechanism of Action

fluconazole will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosamprenavirfosamprenavir will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosamprenavir will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosaprepitantfosaprepitant will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosaprepitant will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Shelf-life, Storage & Dosage Form

fosphenytoinfosphenytoin will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Potent CYP3A4 inducers are expected to cause substantial decreases in sildenafil plasma levels fosphenytoin will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Potent CYP3A4 inducers are expected to cause substantial decreases in sildenafil plasma levels gepotidacingepotidacin increases levels of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If possible, avoid with sensitive substrates that are are extensively metabolized by CYP3A4 and have a narrow therapeutic index. If unable to avoid, monitor or modify substrate dose according to its prescribing information. labetalollabetalol increases effects of sildenafil by additive vasodilation. labetalol increases effects of sildenafil by additive vasodilation. lapatiniblapatinib will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lapatinib will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Usual Adult Dose for Erectile Dysfunction

idelalisib will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. isoniazidisoniazid will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. isoniazid will increase sildenafil 200 mg the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. istradefyllineistradefylline will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Istradefylline 40 mg/day increased peak levels and AUC of CYP3A4 substrates in clinical trials. lesinurad (DSC)lesinurad (DSC) decreases levels of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lesinurad (DSC) decreases levels of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Are There Any Downsides to Combination Therapy?

gepotidacin increases levels of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. grapefruitgrapefruit will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. grapefruit will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. griseofulvingriseofulvin will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. griseofulvin will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Custom Packaging & Labeling

hydrocortisonehydrocortisone will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. hydrocortisone will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. idelalisibidelalisib will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration of sildenafil with strong CYP3A4 inhibitors is not recommended. If using Viagra, consider decreasing starting dose. letermovirletermovir increases levels of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. letermovir increases levels of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Situation	Advice	Notes
Before Sexual Activity	Take sublingually 15-30 mins before intended activity	Do not take more than once in 24 hours
Missed Dose	Not applicable; taken as needed	Do not double dose
Long-term Use	Consult healthcare provider for ongoing management	Monitor for side effects

When amlodipine and sildenafil were used in combination, each agent independently exerted its own blood pressure lowering effect. lorlatiniblorlatinib will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Dosage and Administration Guidelines

enzalutamideenzalutamide will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Potent CYP3A4 inducers are expected to cause substantial decreases in sildenafil plasma levels enzalutamide will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Potent CYP3A4 inducers are expected to cause substantial decreases in sildenafil plasma levels epoprostenolepoprostenol increases effects of sildenafil by additive vasodilation. epoprostenol increases effects of sildenafil by additive vasodilation. erythromycin baseerythromycin base will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Who should not take sildenafil?

Consider a starting dose of 25 mg in patients treated with erythromycin. erythromycin base will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. erythromycin ethylsuccinate will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. erythromycin lactobionateerythromycin lactobionate will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. erythromycin lactobionate will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Dosage Forms & Strengths

erythromycin stearateerythromycin stearate will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. erythromycin stearate will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. esmololesmolol increases effects of sildenafil by additive vasodilation. esmolol increases sildenafil 25 mg tablets effects of sildenafil by additive vasodilation. etravirineetravirine will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lorlatinib will decrease the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Sildenafil citrate enhances blood flow to penile tissue.
The sublingual tablets offer rapid onset compared to oral forms.
Used in the treatment of pulmonary arterial hypertension.
Take the tablet approximately 30 minutes before sexual activity.
Avoid high-fat meals before taking the medication.
Patients with heart conditions should seek medical advice first.
Do not crush or swallow the tablet; allow it to dissolve under tongue.
Potential interactions with other vasodilators exist.
Patients should monitor for signs of adverse reactions.
Keep out of reach of children and pets.
Usage should be based on the healthcare provider’s guidance.

mavacamtensildenafil increases levels of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. Modify mavacamten dose if coadministered with weak or moderate CYP2C19 inhibitors. sildenafil increases levels of mavacamten by affecting hepatic enzyme CYP2C19 metabolism.

Sildenafil citrate sublingual tablets are used for erectile dysfunction treatment.
These tablets dissolve under the tongue for quick absorption.
The recommended dose is typically 100mg per administration.
Sublingual form bypasses digestive enzymes, leading to faster action.
Use under medical supervision to avoid adverse effects.
Do not exceed the prescribed dosage to prevent toxicity.
Store in a cool, dry place away from sunlight.
Not suitable for individuals on nitrate medications.
Common side effects include headache and flushing.
Consult a doctor before starting sildenafil therapy.
Avoid alcohol when taking sublingual sildenafil tablets.

mavorixaformavorixafor will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor for adverse effects of sensitive CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor).

Sildenafil citrate sublingual tablets are available by prescription only.
They are typically used when other erectile dysfunction medications are ineffective.
The sublingual method provides quicker results than traditional pills.
Patients should inform their doctor of all medications before use.
Avoid using these tablets if allergic to sildenafil.
The medication may cause dizziness or vision changes.
Do not use these tablets with grapefruit or grapefruit juice.
Overuse can lead to priapism, a prolonged erection requiring medical attention.
The tablets are designed to degrade under the tongue, not for swallowing.
Regular medical check-ups are recommended during treatment.
Proper disposal of unused medication prevents misuse.

mavorixafor will increase the level or effect of sildenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Interacting Drug	Effect on Sildenafil	Concern Level	Comments
Nitrates	Potentiates hypotension	High	Contraindicated
Alpha-blockers	Increased hypotensive effect	Moderate	Use with caution
CYP3A4 Inhibitors	Increased plasma levels	High	Dose adjustment may be needed